Ed Shovelin: Extending the Platelet Aggregation Testing Window to 72 Hours
Ed Shovelin, Operations and Engineering Manager at Pplus Medical Limited, reposted from Pplus Medical Limited on LinkedIn:
“Under time pressure to complete aggregation testing within just 4 hours? The DSD Ultra can help.
Our latest innovation, the DSD Ultra, has been specifically engineered to preserve platelet function in platelet samples prior to aggregation testing. The device has been developed to significantly extend the practical aggregation testing window, from the current approximately 4-hour limitation to as long as 72 hours.
This innovation directly addresses one of the major logistical challenges in platelet function testing: the tight time constraints associated with sample transport, scheduling, and access to specialist laboratories. By preserving platelet responsiveness for substantially longer, the DSD Ultra enables greater flexibility in sample handling and testing workflows.
As the latest addition to Pplus Medical’s portfolio of platelet storage innovations, the DSD Ultra has been developed to help laboratories overcome real-world challenges in platelet function testing.
For laboratories facing time pressure or transport delays, the DSD Ultra offers a practical solution for extending the aggregation testing window while maintaining platelet functionality for downstream analysis.”

Stay updated with Hemostasis Today.
-
Oct 8, 2026, 23:27Shayan Mohammadmoradi: Happy to Be Back at the Midwest Platelet Conference for Its 20th Meeting
-
Oct 8, 2026, 23:18Lorena Arranz: Honoured to Contribute to the 6th Global MPN Symposium
-
Oct 8, 2026, 23:06Denis Oduor: Serving Citizens and Saving Lives Through Blood Donation During National Customer Service Week 2026
-
Oct 8, 2026, 22:51Jan Hartmann: Speaking on Global Trends in Plasma Collection at the 50th Meeting of the Japanese Society of Blood Services
-
Oct 8, 2026, 22:49Akshat Jain: Proud to Announce the Publication of Advances in Sickle Cell Disease
-
Oct 8, 2026, 22:48Abdulla A. Damluji: Anticancer Drugs and Thrombosis Mechanisms, Risk Factors, and Prevention
-
Oct 8, 2026, 22:46Miguel Escobar: My Research on Oral Health and Hemophilia
-
Oct 8, 2026, 22:44ISTH 2027 Abstract Submission Opens November 23
-
Oct 8, 2026, 22:41Kunihiro Hattori Pioneering Research for People With Hemophilia A – The Albert and Mary Lasker Foundation